Why you haven't lost weight on Mounjaro (and what's actually happening)

The biggest misconception: slow progress means Mounjaro isn't working

Many people start tirzepatide expecting visible results within a week or two. When the scales barely move in the first month, the instinct is to assume something is wrong. This is the most common misconception about the medicine, and it's worth correcting clearly: slow early progress is the expected pattern, not a sign of failure.

The 2.5mg first dose exists to prepare your body, reducing the nausea and gastrointestinal discomfort that can accompany a higher starting dose. At that level, appetite suppression is modest and calorie reduction is limited. Most people don't see consistent weight loss until they've moved beyond the starter dose and reached a dose their body actually responds to therapeutically. That transition takes time. If you're not seeing any change yet on Mounjaro, the dose you're currently on matters enormously to that answer.

Retaining water, constipation (a common early side effect), and hormonal fluctuations can all mask fat loss even when it's genuinely occurring. The number on the scale at any single moment is an incomplete picture. Taking body measurements alongside weight gives a more accurate view of what's actually changing. Our prescribers at nume hear this concern regularly, it's one of the most common things people raise in aftercare conversations.

Why the first few weeks often show little or no change

Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) that govern appetite, fullness and how quickly food leaves the stomach. That process takes time to translate into meaningful calorie reduction, especially at lower doses. The body also has a strong physiological resistance to weight loss; it compensates by adjusting hunger hormones and metabolic rate, which is exactly why lifestyle change alone so rarely produces lasting results.

Add to this the adjustment effects: nausea, changes in appetite that come and go, early fatigue. Some people eat less in week one simply because they feel unwell, then stabilise, and the scale reflects that unevenness. This is not stalling; it's the system settling. According to NHS guidance on tirzepatide, GI effects are most common at the start of treatment and after dose increases, and generally ease within days to a couple of weeks.

Timing can matter in unexpected ways too. If you started in a heavy social period (a holiday, the Christmas stretch, a big week at work) your calorie environment may have counteracted the medicine's early effect. One patient told our team they'd started in the week before a long bank holiday and eaten normally throughout; the first real progress came the following month, when routine returned.

What to check if you've been on a higher dose and progress has stopped

A plateau after initial weight loss is a different situation from no loss at the start. If you've been on a stable higher dose for several weeks and the scales have stopped moving, there are a few things worth examining honestly before concluding the treatment isn't working.

Calorie creep is real: as nausea fades and appetite returns to a new normal, portion sizes can quietly drift upward. Protein intake matters here, tirzepatide reduces overall appetite, but if meals are lower in protein and fibre, hunger returns faster and satiety is shorter. Alcohol adds hidden calories and can blunt the medicine's appetite effect. The NHS Better Health guidance on losing weight covers the practical dietary principles that support treatment, and they apply regardless of what medicine you're taking.

Sleep and stress both affect cortisol, which in turn affects fat storage and water retention. These are not minor variables. If you're not losing weight despite being on Mounjaro at a higher dose, your prescriber can review whether the current dose is still the right one, or whether other factors need addressing. For a more detailed look at why the scales can stay stubbornly still even when you feel you're doing everything right, our page on not having lost any weight on Mounjaro walks through the most likely reasons in detail. For a more detailed look at weekly fluctuations specifically, there's a separate page on why weight can stall week to week that covers this in more depth.

When to raise this with your prescriber, and what nume (nume) can do

If you've been on a consistent dose for more than six weeks and have seen no movement at all, that's worth discussing with your prescriber rather than waiting it out. It may be that a dose increase is clinically appropriate, or that there are factors in your health history that need reviewing. NICE's appraisal of tirzepatide notes that continuing treatment beyond six months at the highest tolerated dose is reviewed if less than 5% weight loss has occurred, which tells you that the clinical framework already expects some people to need that conversation. You can read more about how the medicine works and what clinical oversight looks like on our Mounjaro treatment page.

At nume, every repeat order is reviewed by a GPhC-registered prescriber before anything is dispatched. That review isn't a formality, it's a genuine check on how treatment is going, including whether the current dose and approach are still right for you. If you'd like to explore whether treatment is clinically suitable in the first place, our free consultation is the starting point. No waiting list, no referral needed.